Cartalax
What the molecule is, where the sequence comes from, and what it binds. This page does not describe what Cartalax does.
Structure
What Cartalax is
Origin. A short synthetic peptide from the Khavinson bioregulator series.
Molecular target. Characterised structurally; no defined receptor is established in the literature.
Both statements are facts about the molecule and can be checked against any reference database. Neither is a statement about an outcome, and this page makes none.
Grouped by structure
Short bioregulators
Two to four residue peptides from the Khavinson series and related short sequences.
Compounds on this site are grouped by what the molecule is, not by what anyone intends to do with it. Cartalax sits with 1 other compound in this group because of its structure and its target, and for no other reason.
Compared side by side: Cartalax vs Epithalon.
Read next
Cartalax elsewhere on the site
Literature
Sources
Handling and documentation
The parts that apply to every compound
Documentation
Tested, with the certificate published
Cartalax is tested by an independent lab. The latest certificate is on its product page.

